In REDEFINE 1, which enrolled 3,400 adults without diabetes but with at least one weight-related condition, CagriSema led to an average weight loss of 20.4% at Week 68 , compared to 14.9% with semaglutide, 11.5% with cagrilintide, and 3% with placebo
Semaglutide injections for weight loss may cause various side effects that vary in severity and duration
Example: A 5 mg vial of semaglutide reconstituted in 1 mL gives you 5,000 mcg/mL
Many people find that once they stop taking the medication, hunger levels return to normal , making weight regain common
Expected timeline for results Setting realistic timeline expectations prevents premature discontinuation or unrealistic disappointment
Monitoring & Maintenance Regular check-ins throughout the program